Comments to China National Intellectual Property Administration (CNIPA) on the Patent Examination Guidelines (Revised draft for comment)

2022-12-15 | Beijing, Shanghai

On 15th December, European Chamber IPR Working Group submitted comments to China National Intellectual Property Administration (CNIPA) on the Patent Examination Guidelines (Revised draft for comments).

Member companies submitted detailed comments and suggestions. Overall, the revised draft mainly aims at supporting amendments to the new Patent Law and fulfilling requirements for the implementation, which are improvement of the legislation of the Patent Law system. The revised draft guideline involves pharmaceutical patent term extension (PTE), which is of great significance and value to encourage drug innovation, and it is hoped that it will be implemented as soon as possible. However, some sections still have room for improvement.